Am J Transplant, Volume 18, Suppl 3 Archives - Page 164 of 211 - ATC Abstracts

2018 American Transplant Congress
Influence of mTOR Inhibitors on Metabolic Outcomes One Year after Kidney Transplantation: The Role of Pre-Transplantation Diabetes
D. Cucchiari,¹ S. Karam,² P. Ventura-Aguiar,¹ J. Torregrosa,¹ F. Diekmann.¹
¹Renal Transplant Unit, Hospital Clínic, Barcelona, Spain; ²Department of Medicine, Saint George Hospital, Beirut, Lebanon.
INTRODUCTION: mTOR inhibitors alter lipids and carbohydrate metabolism in kidney transplant recipients. Little is known if there is any difference between patients who were already…
2018 American Transplant Congress
Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure
K. Takahashi,¹ S. Nagai,² M. Safwan,² K. Collins,² M. Rizzari,² A. Yoshida,² N. Ohkohchi,¹ M. Abouljoud.²
¹Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan; ²Transplant, Henry Ford Hospital, Detroit, MI.
Background; Recently, platelet count and lactate level after liver transplantation (LT) have been both separately reported as predictors of graft failure. In this study, we…
2018 American Transplant Congress
Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe
A. Cimeno, S. Sultan, J. Alvarez-Casas, S. Hanish, D. Bruno, W. Hutson, D. Stein, T. Scalea, R. Barth, J. LaMattina.
University of Maryland School of Medicine, Baltimore, MD.
Background: Increased worldwide focus on maximal donor utilization and transplantation of patients once considered too ill to survive liver transplantation may increase the otherwise rare…
2018 American Transplant Congress
The Neutrophil to Lymphocyte Ratio is Confounded by MELD in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation
J. McVey, K. Sasaki, F. Dan, Q. Cristiano, H. Koji, M. Charles, A. Federico.
Department of General Surgery Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.
Background: Biological markers such as the pre-operative neutrophil to lymphocyte ratio (NLR) have been suggested to be valuable indicators of recurrence and overall survival after…
2018 American Transplant Congress
Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes
L. De Gregorio,¹ E. Bugeaud,¹ G. Galliano,² H. Bohorquez,¹ D. Bruce,¹ I. Carmody,¹ A. Cohen,¹ J. Seal,¹ D. Sonnier,¹ A. Mathur,¹ G. Loss.¹
¹Abdominal Transplant Surgery, Ochsner Clinic Foundation, New Orleans, LA; ²Pathology, Ochsner Clinic Foundation, New Orleans, LA.
INTRODUCTIONGraft steatosis is a risk factor for early allograft dysfunction (EAD) and is thought to portend inferior transplant outcomes. The impact of total steatosis, combining…
2018 American Transplant Congress
Racial Differences in Patient-Perceived Barriers to Starting the Kidney Transplant Evaluation
R. Hamoda, L. McPherson, K. Lipford, J. Gander, S. Pastan, R. Patzer.
Emory University, Atlanta, GA.
Overview: Racial disparities in access to kidney transplantation persist along multiple transplant steps, including start of the transplant evaluation. No studies have identified barriers that…
2018 American Transplant Congress
Racial Differences in Rates of Malignant and Infectious Cutaneous Genital Disease after Solid Organ Transplantation
M. Larijani,¹ K. Nadhan,¹ J. Abbott,¹ A. Doyle,² C. Chung.¹
¹Department of Dermatology, Drexel University, Philadelphia, PA; ²Department of Internal Medicine, University of Virginia, Charlottesville, VA.
Purpose: To describe the prevalence and types of genital lesions observed in OTRsMethods: This retrospective review included 496 OTRs who underwent full skin examination at…
2018 American Transplant Congress
Outcomes of Enteric Conversion of Bladder Drained Pancreas; over a Decade of Experience at a Single Center
S. Riad,¹ D. Keys,¹ V. Vakil,¹ S. Jackson,² D. Berglund,² A. Matas,³ R. Kandaswamy.³
¹U of MN, Minneapolis; ²Fairview, Minneapolis; ³U of MN, Minneapolis.
Background: Bladder drainage in pancreas transplantation has been used to enable early detection of rejection. This technique has declined due to concern over complications necessitating…
2018 American Transplant Congress
Ideal Body Weight versus Actual Body Weight for Rabbit Antithymocyte Globulin Induction in Pancreas Transplantation
E. Martinez,¹ D. Felix,² J. Wiegel,² T. Al-Qaoud,¹ G. Leverson,¹ A. Condon,² R. Redfield,¹ J. Odorico.¹
¹Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI; ²Department of Pharmacy, UW Health, Madison, WI.
Purpose: Rabbit antithymocyte globulin (rATG) is the most commonly used induction agent in solid organ pancreas transplantation. The optimal induction dosing of rATG, has not…
2018 American Transplant Congress
Increased Risk of Early Graft Loss in Pancreas Transplant: A Retrospective Review of the UNOS Database
E. Steen,¹ C. Liu,² E. Siskind,² J. Ortiz.¹
¹Surgery, University of Toledo Medical Center, Toledo, OH; ²Surgery, Inova Fairfax Hospital, Annandale, VA.
Introduction: Pancreas transplant is an established cure for Type 1 diabetes. Nonetheless, early graft loss is not infrequent. We sought to analyze all of the…